{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,21]],"date-time":"2026-08-21T11:57:31Z","timestamp":1787313451711,"version":"build-2736575974"},"reference-count":57,"publisher":"MDPI AG","issue":"5","license":[{"start":{"date-parts":[[2025,2,28]],"date-time":"2025-02-28T00:00:00Z","timestamp":1740700800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"name":"CAMS Innovation Fund for Medical Sciences","award":["2023-I2M-2-006"],"award-info":[{"award-number":["2023-I2M-2-006"]}]},{"name":"CAMS Innovation Fund for Medical Sciences","award":["2022-I2M-2-002"],"award-info":[{"award-number":["2022-I2M-2-002"]}]},{"name":"CAMS Innovation Fund for Medical Sciences","award":["2021-I2M-1-070"],"award-info":[{"award-number":["2021-I2M-1-070"]}]}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["IJMS"],"abstract":"<jats:p>Liver fibrosis, caused by chronic hepatic injury, is a major threat to human health worldwide, as there are no specific drugs available for its treatment. Natural compounds, such as berberine (BBR) and quercetin (QR), have shown the ability to regulate energy metabolism and protect the liver without significant adverse effects. Additionally, combination therapy (the cocktail therapy approach), using multiple drugs, has shown promise in treating complicated conditions, including liver injury. In this study, we prepared a salt formulation of BBR and QR (BQS) to enhance their combined effect on liver fibrosis. The formation of BQS was confirmed using various analytical techniques, including nuclear magnetic resonance spectroscopy (NMR), differential scanning calorimetry (DSC), Fourier-transform infrared spectroscopy (FTIR), powder X-ray diffractometry (PXRD), and scanning electron microscopy (SEM). The results demonstrated that the dissolution efficiency and bioavailability of QR significantly increased in the BQS form, aligning with that of BBR, compared to the physically mixed (BQP) form. Moreover, BQS exhibited a superior inhibitory effect on fibrosis compared to BQP in the human hepatic stellate cell line LX-2 by modulating lipid accumulation, inflammation, apoptosis, and the cell cycle. Furthermore, in a mouse model of hepatic fibrosis induced by methionine and choline-deficient (MCD) diets, BQS demonstrated enhanced anti-fibrotic activities compared to BQP. These findings suggest that BQS holds promise as a potential alternative treatment for liver fibrosis. Importantly, this study provides novel insights into achieving a cocktail effect through the salt formation of two or more drugs. The results highlight the potential of salt formulations in enhancing the therapeutic efficacy and consistent biological processes of drug combinations.<\/jats:p>","DOI":"10.3390\/ijms26052193","type":"journal-article","created":{"date-parts":[[2025,2,28]],"date-time":"2025-02-28T08:05:54Z","timestamp":1740729954000},"page":"2193","update-policy":"https:\/\/doi.org\/10.3390\/mdpi_crossmark_policy","source":"Crossref","is-referenced-by-count":4,"title":["Enhancing the Therapeutic Efficacy of Berberine and Quercetin Through Salt Formulation for Liver Fibrosis Treatment"],"prefix":"10.3390","volume":"26","author":[{"given":"Yangyang","family":"Cheng","sequence":"first","affiliation":[{"name":"Institute of Medicinal Biotechnology, Chinese Academy of Medical Science & Peking Union Medical College, Beijing 100050, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Haoyang","family":"Yu","sequence":"additional","affiliation":[{"name":"Institute of Medicinal Biotechnology, Chinese Academy of Medical Science & Peking Union Medical College, Beijing 100050, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sitong","family":"Yang","sequence":"additional","affiliation":[{"name":"Institute of Medicinal Biotechnology, Chinese Academy of Medical Science & Peking Union Medical College, Beijing 100050, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiaolian","family":"Tian","sequence":"additional","affiliation":[{"name":"Institute of Medicinal Biotechnology, Chinese Academy of Medical Science & Peking Union Medical College, Beijing 100050, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mengyu","family":"Zhao","sequence":"additional","affiliation":[{"name":"Institute of Medicinal Biotechnology, Chinese Academy of Medical Science & Peking Union Medical College, Beijing 100050, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ling","family":"Ren","sequence":"additional","affiliation":[{"name":"Institute of Medicinal Biotechnology, Chinese Academy of Medical Science & Peking Union Medical College, Beijing 100050, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0002-7073-7190","authenticated-orcid":false,"given":"Xiuping","family":"Guo","sequence":"additional","affiliation":[{"name":"Institute of Medicinal Biotechnology, Chinese Academy of Medical Science & Peking Union Medical College, Beijing 100050, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chujuan","family":"Hu","sequence":"additional","affiliation":[{"name":"Institute of Medicinal Biotechnology, Chinese Academy of Medical Science & Peking Union Medical College, Beijing 100050, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jiandong","family":"Jiang","sequence":"additional","affiliation":[{"name":"Institute of Medicinal Biotechnology, Chinese Academy of Medical Science & Peking Union Medical College, Beijing 100050, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lulu","family":"Wang","sequence":"additional","affiliation":[{"name":"Institute of Medicinal Biotechnology, Chinese Academy of Medical Science & Peking Union Medical College, Beijing 100050, China"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1968","published-online":{"date-parts":[[2025,2,28]]},"reference":[{"key":"ref_1","doi-asserted-by":"crossref","first-page":"2672","DOI":"10.1002\/hep.30251","article-title":"Global Perspectives on Nonalcoholic Fatty Liver Disease and Nonalcoholic Steatohepatitis","volume":"69","author":"Younossi","year":"2019","journal-title":"Hepatology"},{"key":"ref_2","doi-asserted-by":"crossref","first-page":"908","DOI":"10.1038\/s41591-018-0104-9","article-title":"Mechanisms of NAFLD development and therapeutic strategies","volume":"24","author":"Friedman","year":"2018","journal-title":"Nat. Med."},{"key":"ref_3","doi-asserted-by":"crossref","first-page":"6304","DOI":"10.3748\/wjg.v26.i41.6304","article-title":"Efficacy and safety of anti-hepatic fibrosis drugs","volume":"26","author":"Damiris","year":"2020","journal-title":"World J. Gastroenterol."},{"key":"ref_4","doi-asserted-by":"crossref","first-page":"3768","DOI":"10.1073\/pnas.1914985117","article-title":"Development of an antibody cocktail for treatment of Sudan virus infection","volume":"117","author":"Herbert","year":"2020","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"ref_5","doi-asserted-by":"crossref","first-page":"827","DOI":"10.1097\/QAD.0000000000000971","article-title":"Co-delivery of HIV-1 entry inhibitor and nonnucleoside reverse transcriptase inhibitor shuttled by nanoparticles: Cocktail therapeutic strategy for antiviral therapy","volume":"30","author":"Li","year":"2016","journal-title":"AIDS"},{"key":"ref_6","doi-asserted-by":"crossref","unstructured":"Plumet, L., Ahmad-Mansour, N., Dunyach-Remy, C., Kissa, K., Sotto, A., Lavigne, J.P., Costechareyre, D., and Molle, V. (2022). Bacteriophage Therapy for Staphylococcus Aureus Infections: A Review of Animal Models, Treatments, and Clinical Trials. Front. Cell. Infect. Microbiol., 12.","DOI":"10.3389\/fcimb.2022.907314"},{"key":"ref_7","doi-asserted-by":"crossref","first-page":"238","DOI":"10.1056\/NEJMoa2035002","article-title":"REGN-COV2, a Neutralizing Antibody Cocktail, in Outpatients with COVID-19","volume":"384","author":"Weinreich","year":"2021","journal-title":"New Engl. J. Med."},{"key":"ref_8","doi-asserted-by":"crossref","unstructured":"Lin, L.J., and Huang, H.Y. (2020). DFSG, a novel herbal cocktail with anti-asthma activity, suppressed MUC5AC in A549 cells and alleviated allergic airway hypersensitivity and inflammatory cell infiltration in a chronic asthma mouse model. Biomed. Pharmacother. = Biomed. Pharmacother., 121.","DOI":"10.1016\/j.biopha.2019.109584"},{"key":"ref_9","doi-asserted-by":"crossref","first-page":"1007","DOI":"10.2174\/1567205016666191106095038","article-title":"Consideration of a Pharmacological Combinatorial Approach to Inhibit Chronic Inflammation in Alzheimer\u2019s Disease","volume":"16","author":"McLarnon","year":"2019","journal-title":"Curr. Alzheimer Res."},{"key":"ref_10","doi-asserted-by":"crossref","unstructured":"Zhu, Y., Xie, N., Chai, Y., Nie, Y., Liu, K., Liu, Y., Yang, Y., Su, J., and Zhang, C. (2022). Apoptosis Induction, a Sharp Edge of Berberine to Exert Anti-Cancer Effects, Focus on Breast, Lung, and Liver Cancer. Front. Pharmacol., 13.","DOI":"10.3389\/fphar.2022.803717"},{"key":"ref_11","doi-asserted-by":"crossref","unstructured":"Xu, X., Yi, H., Wu, J., Kuang, T., Zhang, J., Li, Q., Du, H., Xu, T., Jiang, G., and Fan, G. (2021). Therapeutic effect of berberine on metabolic diseases: Both pharmacological data and clinical evidence. Biomed. Pharmacother. = Biomed. Pharmacother., 133.","DOI":"10.1016\/j.biopha.2020.110984"},{"key":"ref_12","doi-asserted-by":"crossref","first-page":"6770","DOI":"10.1021\/acsnano.9b01346","article-title":"Natural Berberine-Based Chinese Herb Medicine Assembled Nanostructures with Modified Antibacterial Application","volume":"13","author":"Li","year":"2019","journal-title":"ACS Nano"},{"key":"ref_13","doi-asserted-by":"crossref","first-page":"374","DOI":"10.1038\/s41420-021-00768-7","article-title":"Berberine alleviates liver fibrosis through inducing ferrous redox to activate ROS-mediated hepatic stellate cells ferroptosis","volume":"7","author":"Yi","year":"2021","journal-title":"Cell Death Discov."},{"key":"ref_14","doi-asserted-by":"crossref","first-page":"8762345","DOI":"10.1155\/2016\/8762345","article-title":"Berberine Inhibition of Fibrogenesis in a Rat Model of Liver Fibrosis and in Hepatic Stellate Cells","volume":"2016","author":"Wang","year":"2016","journal-title":"Evid. Based Complement. Altern. Med."},{"key":"ref_15","doi-asserted-by":"crossref","first-page":"173655","DOI":"10.1016\/j.ejphar.2020.173655","article-title":"The pharmacological activity of berberine, a review for liver protection","volume":"890","author":"Zhou","year":"2021","journal-title":"Eur. J. Pharmacol."},{"key":"ref_16","doi-asserted-by":"crossref","unstructured":"Wang, Y., Zhao, Z., Yan, Y., Qiang, X., Zhou, C., Li, R., Chen, H., and Zhang, Y. (2016). Demethyleneberberine Protects against Hepatic Fibrosis in Mice by Modulating NF-\u03baB Signaling. Int. J. Mol. Sci., 17.","DOI":"10.3390\/ijms17071036"},{"key":"ref_17","doi-asserted-by":"crossref","first-page":"1285","DOI":"10.1038\/s41401-021-00736-y","article-title":"Berberine remodels adipose tissue to attenuate metabolic disorders by activating sirtuin 3","volume":"43","author":"Li","year":"2022","journal-title":"Acta Pharmacol. Sin."},{"key":"ref_18","doi-asserted-by":"crossref","unstructured":"Nasiri-Ansari, N., Nikolopoulou, C., Papoutsi, K., Kyrou, I., Mantzoros, C.S., Kyriakopoulos, G., Chatzigeorgiou, A., Kalotychou, V., Randeva, M.S., and Chatha, K. (2021). Empagliflozin Attenuates Non-Alcoholic Fatty Liver Disease (NAFLD) in High Fat Diet Fed ApoE(\u2212\/\u2212) Mice by Activating Autophagy and Reducing ER Stress and Apoptosis. Int. J. Mol. Sci., 22.","DOI":"10.3390\/ijms22020818"},{"key":"ref_19","doi-asserted-by":"crossref","unstructured":"Liu, X., Wang, L., Tan, S., Chen, Z., Wu, B., and Wu, X. (2022). Therapeutic Effects of Berberine on Liver Fibrosis are associated with Lipid Metabolism and Intestinal Flora. Front. Pharmacol., 13.","DOI":"10.3389\/fphar.2022.814871"},{"key":"ref_20","doi-asserted-by":"crossref","first-page":"518","DOI":"10.1089\/jmf.2012.0175","article-title":"Resolution of liver fibrosis by isoquinoline alkaloid berberine in CCl4-intoxicated mice is mediated by suppression of oxidative stress and upregulation of MMP-2 expression","volume":"16","author":"Jakovac","year":"2013","journal-title":"J. Med. Food"},{"key":"ref_21","doi-asserted-by":"crossref","first-page":"91","DOI":"10.1016\/j.cbi.2018.08.016","article-title":"Antioxidant and anti-inflammatory activities of berberine attenuate hepatic fibrosis induced by thioacetamide injection in rats","volume":"294","author":"Eissa","year":"2018","journal-title":"Chem.-Biol. Interact."},{"key":"ref_22","doi-asserted-by":"crossref","unstructured":"Tang, S.M., Deng, X.T., Zhou, J., Li, Q.P., Ge, X.X., and Miao, L. (2020). Pharmacological basis and new insights of quercetin action in respect to its anti-cancer effects. Biomed. Pharmacother. = Biomed. Pharmacother., 121.","DOI":"10.1016\/j.biopha.2019.109604"},{"key":"ref_23","doi-asserted-by":"crossref","unstructured":"Grewal, A.K., Singh, T.G., Sharma, D., Sharma, V., Singh, M., Rahman, M.H., Najda, A., Walasek-Janusz, M., Kamel, M., and Albadrani, G.M. (2021). Mechanistic insights and perspectives involved in neuroprotective action of quercetin. Biomed. Pharmacother. = Biomed. Pharmacother., 140.","DOI":"10.1016\/j.biopha.2021.111729"},{"key":"ref_24","doi-asserted-by":"crossref","unstructured":"Chen, L., Liu, J., Mei, G., Chen, H., Peng, S., Zhao, Y., Yao, P., and Tang, Y. (2021). Quercetin and non-alcoholic fatty liver disease: A review based on experimental data and bioinformatic analysis. Food Chem. Toxicol. Int. J. Publ. Br. Ind. Biol. Res. Assoc., 154.","DOI":"10.1016\/j.fct.2021.112314"},{"key":"ref_25","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.toxlet.2016.09.002","article-title":"Quercetin attenuates the activation of hepatic stellate cells and liver fibrosis in mice through modulation of HMGB1-TLR2\/4-NF-\u03baB signaling pathways","volume":"261","author":"Li","year":"2016","journal-title":"Toxicol. Lett."},{"key":"ref_26","doi-asserted-by":"crossref","unstructured":"Wu, L., Zhang, Q., Mo, W., Feng, J., Li, S., Li, J., Liu, T., Xu, S., Wang, W., and Lu, X. (2017). Quercetin prevents hepatic fibrosis by inhibiting hepatic stellate cell activation and reducing autophagy via the TGF-\u03b21\/Smads and PI3K\/Akt pathways. Sci. Rep., 7.","DOI":"10.1038\/s41598-017-09673-5"},{"key":"ref_27","doi-asserted-by":"crossref","unstructured":"Li, X., Jin, Q., Yao, Q., Xu, B., Li, L., Zhang, S., and Tu, C. (2018). The Flavonoid Quercetin Ameliorates Liver Inflammation and Fibrosis by Regulating Hepatic Macrophages Activation and Polarization in Mice. Front. Pharmacol., 9.","DOI":"10.3389\/fphar.2018.00072"},{"key":"ref_28","doi-asserted-by":"crossref","first-page":"5506","DOI":"10.1016\/j.bmc.2017.08.013","article-title":"The design and synthesis of a novel compound of berberine and baicalein that inhibits the efficacy of lipid accumulation in 3T3-L1 adipocytes","volume":"25","author":"Hao","year":"2017","journal-title":"Bioorg. Med. Chem."},{"key":"ref_29","doi-asserted-by":"crossref","unstructured":"Jia, D., Dou, Y., Li, Z., Zhou, X., Gao, Y., Chen, K., Cong, W., Ma, M., Wu, Z., and Li, W. (2020). Design, synthesis and evaluation of a baicalin and berberine hybrid compound as therapeutic agent for ulcerative colitis. Bioorg. Med. Chem., 28.","DOI":"10.1016\/j.bmc.2020.115697"},{"key":"ref_30","doi-asserted-by":"crossref","first-page":"1003","DOI":"10.5740\/jaoacint.18-0380","article-title":"Simultaneous Quantification of Pharmacological Markers Quercetin and Berberine Using High-Performance Thin-Layer Chromatography (HPTLC) and High-Performance Liquid Chromatography (HPLC) from a Polyherbal Formulation Pushyanuga Churna","volume":"102","author":"Shailajan","year":"2019","journal-title":"J. AOAC Int."},{"key":"ref_31","doi-asserted-by":"crossref","unstructured":"Urasaki, Y., and Le, T.T. (2022). Functional Complementation of Anti-Adipogenic Phytonutrients for Obesity Prevention and Management. Nutrients, 14.","DOI":"10.3390\/nu14204325"},{"key":"ref_32","doi-asserted-by":"crossref","first-page":"154","DOI":"10.1186\/s10020-021-00414-z","article-title":"The effect and mechanism of Jiao-tai-wan in the treatment of diabetes mellitus with depression based on network pharmacology and experimental analysis","volume":"27","author":"Tang","year":"2021","journal-title":"Mol. Med."},{"key":"ref_33","doi-asserted-by":"crossref","first-page":"151","DOI":"10.1038\/s41575-020-00372-7","article-title":"Molecular and cellular mechanisms of liver fibrosis and its regression","volume":"18","author":"Kisseleva","year":"2021","journal-title":"Nat. Rev. Gastroenterol. Hepatol."},{"key":"ref_34","doi-asserted-by":"crossref","unstructured":"Cano-Mart\u00ednez, A., Bautista-P\u00e9rez, R., Castrej\u00f3n-T\u00e9llez, V., Carre\u00f3n-Torres, E., P\u00e9rez-Torres, I., D\u00edaz-D\u00edaz, E., Flores-Estrada, J., Guarner-Lans, V., and Rubio-Ru\u00edz, M.E. (2021). Resveratrol and Quercetin as Regulators of Inflammatory and Purinergic Receptors to Attenuate Liver Damage Associated to Metabolic Syndrome. Int. J. Mol. Sci., 22.","DOI":"10.3390\/ijms22168939"},{"key":"ref_35","doi-asserted-by":"crossref","first-page":"1533","DOI":"10.1248\/bpb.32.1533","article-title":"Berberine inhibits hepatic stellate cell proliferation and prevents experimental liver fibrosis","volume":"32","author":"Sun","year":"2009","journal-title":"Biol. Pharm. Bull."},{"key":"ref_36","doi-asserted-by":"crossref","first-page":"99","DOI":"10.1007\/s00018-018-2947-0","article-title":"Molecular pathways of nonalcoholic fatty liver disease development and progression","volume":"76","author":"Bessone","year":"2019","journal-title":"Cell. Mol. Life Sci. CMLS"},{"key":"ref_37","doi-asserted-by":"crossref","unstructured":"Mountford, S., Effenberger, M., Noll-Puchta, H., Griessmair, L., Ringleb, A., Haas, S., Denk, G., Reiter, F.P., Mayr, D., and Dinarello, C.A. (2021). Modulation of Liver Inflammation and Fibrosis by Interleukin-37. Front. Immunol., 12.","DOI":"10.3389\/fimmu.2021.603649"},{"key":"ref_38","doi-asserted-by":"crossref","first-page":"325","DOI":"10.1038\/nrneph.2016.48","article-title":"TGF-\u03b2: The master regulator of fibrosis","volume":"12","author":"Meng","year":"2016","journal-title":"Nat. Rev. Nephrol."},{"key":"ref_39","doi-asserted-by":"crossref","first-page":"977","DOI":"10.1089\/ars.2017.7064","article-title":"Role of Platelet-Derived Transforming Growth Factor-\u03b21 and Reactive Oxygen Species in Radiation-Induced Organ Fibrosis","volume":"27","author":"Ahamed","year":"2017","journal-title":"Antioxid. Redox Signal."},{"key":"ref_40","doi-asserted-by":"crossref","first-page":"1617","DOI":"10.1016\/j.biopha.2018.10.005","article-title":"Carvedilol attenuates liver fibrosis by suppressing autophagy and promoting apoptosis in hepatic stellate cells","volume":"108","author":"Meng","year":"2018","journal-title":"Biomed. Pharmacother. = Biomed. Pharmacother."},{"key":"ref_41","doi-asserted-by":"crossref","first-page":"4474","DOI":"10.1038\/s41467-021-24734-0","article-title":"CD8(+) tissue-resident memory T cells promote liver fibrosis resolution by inducing apoptosis of hepatic stellate cells","volume":"12","author":"Koda","year":"2021","journal-title":"Nat. Commun."},{"key":"ref_42","doi-asserted-by":"crossref","first-page":"7312","DOI":"10.3748\/wjg.v20.i23.7312","article-title":"Pathogenesis of liver cirrhosis","volume":"20","author":"Zhou","year":"2014","journal-title":"World J. Gastroenterol."},{"key":"ref_43","doi-asserted-by":"crossref","first-page":"e10124","DOI":"10.15252\/emmm.201810124","article-title":"Liver ASK1 protects from non-alcoholic fatty liver disease and fibrosis","volume":"11","author":"Challa","year":"2019","journal-title":"EMBO Mol. Med."},{"key":"ref_44","doi-asserted-by":"crossref","unstructured":"Zhao, X., Chen, J., Sun, H., Zhang, Y., and Zou, D. (2022). New insights into fibrosis from the ECM degradation perspective: The macrophage-MMP-ECM interaction. Cell Biosci., 12.","DOI":"10.1186\/s13578-022-00856-w"},{"key":"ref_45","doi-asserted-by":"crossref","unstructured":"Roehlen, N., Crouchet, E., and Baumert, T.F. (2020). Liver Fibrosis: Mechanistic Concepts and Therapeutic Perspectives. Cells, 9.","DOI":"10.3390\/cells9040875"},{"key":"ref_46","doi-asserted-by":"crossref","first-page":"225","DOI":"10.1186\/s12967-024-05011-2","article-title":"The clinical efficacy and safety of berberine in the treatment of non-alcoholic fatty liver disease: A meta-analysis and systematic review","volume":"22","author":"Nie","year":"2024","journal-title":"J. Transl. Med."},{"key":"ref_47","doi-asserted-by":"crossref","unstructured":"Fabregat, I., and Caballero-Diaz, D. (2018). Transforming Growth Factor-beta-Induced Cell Plasticity in Liver Fibrosis and Hepatocarcinogenesis. Front. Oncol., 8.","DOI":"10.3389\/fonc.2018.00357"},{"key":"ref_48","doi-asserted-by":"crossref","first-page":"390","DOI":"10.1038\/ejcn.2013.5","article-title":"Effect of quercetin on P-glycoprotein transport ability in Chinese healthy subjects","volume":"67","author":"Wang","year":"2013","journal-title":"Eur. J. Clin. Nutr."},{"key":"ref_49","doi-asserted-by":"crossref","first-page":"7216","DOI":"10.1021\/jm500290c","article-title":"Water-soluble and cleavable quercetin-amino acid conjugates as safe modulators for P-glycoprotein-based multidrug resistance","volume":"57","author":"Kim","year":"2014","journal-title":"J. Med. Chem."},{"key":"ref_50","doi-asserted-by":"crossref","first-page":"563","DOI":"10.1080\/00498254.2018.1478168","article-title":"Effects of quercetin on the pharmacokinetics of losartan and its metabolite EXP3174 in rats","volume":"49","author":"Zhao","year":"2019","journal-title":"Xenobiotica"},{"key":"ref_51","doi-asserted-by":"crossref","unstructured":"Zhang, Z., Shang, J., Yang, Q., Dai, Z., Liang, Y., Lai, C., Feng, T., Zhong, D., Zou, H., and Sun, L. (2023). Exosomes derived from human adipose mesenchymal stem cells ameliorate hepatic fibrosis by inhibiting PI3K\/Akt\/mTOR pathway and remodeling choline metabolism. J. Nanobiotechnol., 21.","DOI":"10.1186\/s12951-023-01788-4"},{"key":"ref_52","doi-asserted-by":"crossref","unstructured":"Yu, H., Zhang, L., Chen, P., Liang, X., Cao, A., Han, J., Wu, X., Zheng, Y., Qin, Y., and Xue, M. (2019). Dietary Bile Acids Enhance Growth, and Alleviate Hepatic Fibrosis Induced by a High Starch Diet via AKT\/FOXO1 and cAMP\/AMPK\/SREBP1 Pathway in Micropterus salmoides. Front. Physiol., 10.","DOI":"10.3389\/fphys.2019.01430"},{"key":"ref_53","doi-asserted-by":"crossref","first-page":"e154333","DOI":"10.1172\/JCI154333","article-title":"Myeloid FoxO1 depletion attenuates hepatic inflammation and prevents nonalcoholic steatohepatitis","volume":"132","author":"Lee","year":"2022","journal-title":"J. Clin. Investig."},{"key":"ref_54","doi-asserted-by":"crossref","first-page":"1025","DOI":"10.1038\/s41467-022-28692-z","article-title":"Kindlin-2 haploinsufficiency protects against fatty liver by targeting Foxo1 in mice","volume":"13","author":"Gao","year":"2022","journal-title":"Nat. Commun."},{"key":"ref_55","doi-asserted-by":"crossref","first-page":"pdb-prot087288","DOI":"10.1101\/pdb.prot087288","article-title":"Quantitation of Apoptosis and Necrosis by Annexin V Binding, Propidium Iodide Uptake, and Flow Cytometry","volume":"2016","author":"Crowley","year":"2016","journal-title":"Cold Spring Harb. Protoc."},{"key":"ref_56","doi-asserted-by":"crossref","first-page":"1635","DOI":"10.1111\/j.1440-1746.2008.05543.x","article-title":"Animal models of NASH: Getting both pathology and metabolic context right","volume":"23","author":"Larter","year":"2008","journal-title":"J. Gastroenterol. Hepatol."},{"key":"ref_57","doi-asserted-by":"crossref","first-page":"1769","DOI":"10.1016\/j.apsb.2020.03.005","article-title":"Functional nano-vector boost anti-atherosclerosis efficacy of berberine in Apoe(\u2212\/\u2212) mice","volume":"10","author":"Ma","year":"2020","journal-title":"Acta Pharm. Sin. B"}],"container-title":["International Journal of Molecular Sciences"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.mdpi.com\/1422-0067\/26\/5\/2193\/pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,10,9]],"date-time":"2025-10-09T16:44:41Z","timestamp":1760028281000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.mdpi.com\/1422-0067\/26\/5\/2193"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,2,28]]},"references-count":57,"journal-issue":{"issue":"5","published-online":{"date-parts":[[2025,3]]}},"alternative-id":["ijms26052193"],"URL":"https:\/\/doi.org\/10.3390\/ijms26052193","relation":{},"ISSN":["1422-0067"],"issn-type":[{"value":"1422-0067","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,2,28]]}}}